APA

Sjoquist K. M., Friedlander M. L., O'Connell R. L., Voysey M., King M. T., Stockler M. R., Oza A. M., Gillies K., Martyn J. K. & Butow P. N. (20141001). Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. : The oncologist.

Chicago

Sjoquist Katrin M, Friedlander Michael L, O'Connell Rachel L, Voysey Merryn, King Madeleine T, Stockler Martin R, Oza Amit M, Gillies Kim, Martyn Julie K and Butow Phyllis N. 20141001. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. : The oncologist.

Harvard

Sjoquist K. M., Friedlander M. L., O'Connell R. L., Voysey M., King M. T., Stockler M. R., Oza A. M., Gillies K., Martyn J. K. and Butow P. N. (20141001). Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. : The oncologist.

MLA

Sjoquist Katrin M, Friedlander Michael L, O'Connell Rachel L, Voysey Merryn, King Madeleine T, Stockler Martin R, Oza Amit M, Gillies Kim, Martyn Julie K and Butow Phyllis N. Hope, quality of life, and benefit from treatment in women having chemotherapy for platinum-resistant/refractory recurrent ovarian cancer: the gynecologic cancer intergroup symptom benefit study. : The oncologist. 20141001.